MEDICAL WEIGHT LOSS
WITH GLP-1 MEDICATIONS
in springville, utah
HOW DO MEDICATIONS LIKE TIRZEPATIDE AND SEMAGLUTIDE WORK?
Glucagon-like peptide (GLP-1) receptor agonist medications, such as tirzepatide and semaglutide offer a multifaceted approach to improving overall health for overweight and obese individuals. These medications work by mimicking the effects of natural GLP-1, a hormone that regulates glucose metabolism and appetite. By stimulating insulin secretion and inhibiting glucagon (natural sugar) release, GLP-1 medications help to control blood sugar levels, making them particularly beneficial for individuals with type 2 diabetes.
Additionally, GLP-1 medications slow down gastric emptying, promoting feelings of fullness and reducing food intake, which can aid in weight loss efforts. Beyond their metabolic effects, GLP-1 medications have demonstrated cardiovascular benefits, such as lowering blood pressure and improving lipid profiles, which contribute to reducing the risk of heart disease—a common comorbidity in overweight and obese individuals. Moreover, by promoting weight loss and improving metabolic parameters, GLP-1 medications can enhance overall quality of life and reduce the burden of obesity-related complications, making them valuable tools in the comprehensive management of obesity and related health conditions.
​
Click here for pricing.
HOW DO I KNOW IT'S SAFE FOR ME TO TAKE THESE MEDICATIONS?
GLP-1 medications are generally safe for individuals who have been diagnosed with type 2 diabetes or who struggle with obesity. However, there are certain considerations and criteria that healthcare providers typically assess before prescribing these medications. GLP-1 medications are particularly suitable for individuals who have not achieved adequate blood sugar control with other oral medications or insulin therapy alone. They are also beneficial for those who are overweight or obese and have difficulty achieving weight loss through lifestyle modifications alone.
Healthcare providers may need to exercise caution when prescribing GLP-1 medications to individuals with a history of pancreatitis, as these medications can potentially increase the risk of this condition. Additionally, individuals with a family or personal history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid GLP-1 medications due to a potential risk of thyroid tumors. Overall, healthcare providers carefully evaluate each patient's medical history, current health status, and individual risk factors to determine the appropriateness of GLP-1 medication therapy, ensuring that the benefits outweigh any potential risks.
WHAT IS THE DIFFERENCE BETWEEN TIRZEPATIDE AND SEMAGLUTIDE?
Semaglutide and tirzepatide are similar medications that work in the same way to help you achieve weight loss and wellness. The table below illustrates the similarities and differences between the two medications. Click here to schedule your free consultation.
EFFECT | TIRZEPATIDE | SEMAGLUTIDE |
---|---|---|
NAUSEA / VOMITING | X | |
CONSTIPATION | X | X |
12-15% TOTAL WEIGHT LOSS | X | X |
20-25% TOTAL WEIGHT LOSS | X | |
INCREASES ENERGY | X | |
AIDS IN BLOOD SUGAR CONTROL | X | X |
REDUCES APPETITE | X | X |
TARGETS GLP-1 RECEPTOR | X | X |
SLOWS GASTRIC EMPTYING | X | |
TARGETS GIP RECEPTOR | X |